Your browser doesn't support javascript.
loading
[Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)]. / Mise à jour des recommandations pour le choix des unités de sang placentaire en greffe de cellules souches hématopoïétiques (atelier SFGM-TC).
Dubois, Valérie; Blandin, Lucie; Duclaut, Marion; Duquesne, Alix; Faivre, Lionel; Ferru-Clement, Romain; Roy, Jean; Walencik, Alexandre; Magro, Leonardo; Garnier, Federico.
Affiliation
  • Dubois V; Établissement Français du Sang Auvergne Rhône Alpes site de Lyon, 111, rue Elisée Reclus, 69150 Décines, France. Electronic address: valerie.dubois@efs.sante.fr.
  • Blandin L; Laboratoire d'Histocompatibilité et Immunogénétique, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France.
  • Duclaut M; Laboratoire d'Immunologie et Immunogénétique, CHU de Bordeaux, Hôpital Pellegrin, Place Amélie Raba Léon, 33000 Bordeaux, France.
  • Duquesne A; Établissement Français du Sang Centre Pays de la Loire, Site Atlantic Bio GMP, Service Thérapie cellulaire, 2, rue Aronnax, 44800 Saint Herblain, France.
  • Faivre L; Unité de Thérapie Cellulaire, Hôpital Saint-Louis, AP-HP, Paris, France.
  • Ferru-Clement R; Laboratoire d'Histocompatibilité et Immunogénétique. Etablissement Français du Sang Nouvelle Aquitaine, site de Poitiers, 350, avenue Jacques Cœur-La Milétrie, 86000 Poitiers, France.
  • Roy J; Hôpital Maisonneuve-Rosemont, 5415 de l'Assomption, Montréal, H1T 2M4Québec, Canada.
  • Walencik A; Établissement Français du Sang Centre Pays de la Loire, Laboratoire HLA de Nantes, 34, boulevard Jean-Monnet, 44000 Nantes, France.
  • Magro L; Hôpital Claude Huriez, CHU Lille, rue Michel Polonovski, 59037 Lille cedex, France.
  • Garnier F; Agence de la biomédecine, 1, avenue du Stade de France, 93212 Saint-Denis la Plaine cedex, France.
Bull Cancer ; 2024 Mar 13.
Article in Fr | MEDLINE | ID: mdl-38485627
ABSTRACT
Changing practices and the limited use of cord blood units as a source of cells for allogeneic hematopoietic stem cell transplants (HSC) led us to reconsider the recommendations established in 2011 and 2012, and to propose an update incorporating recent bibliographic data. If HLA compatibility was until now established at low resolution for HLA-A and B loci, and at high resolution for HLA-DRB1, the recent papers are converging towards an increase in the level of resolution, making way for a compatibility now defined in high resolution for all the considered loci, and the inclusion of the HLA-C locus, in order to establish a level of HLA compatibility on 8 alleles (HLA-A, B, C and DRB1). The CD34+ dose is a determining factor in hematopoietic reconstitution but it is not correlated with the total nucleated cells content. This is why we recommend taking these two data into account when choosing a cord blood unit. The recommendations established by our group are presented as a flow chart taking into account the characteristics of the underlying pathology (malignant or non-malignant), the cell dose and the HLA compatibility criteria, as well as criteria linked to the banks in which units are stored.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: Fr Journal: Bull Cancer Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: Fr Journal: Bull Cancer Year: 2024 Document type: Article
...